Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 15; no. suppl-4; pp. iv133 - iv138
Main Author	Eccles, D.M.
Format	Journal Article Conference Proceeding
Language	English
Published	Oxford Elsevier Ltd 01.01.2004 Oxford University Press
Subjects	Antineoplastic agents Biological and medical sciences Breast Neoplasms - genetics Europe Female Female genital diseases Genes, BRCA1 Genes, BRCA2 Genetic Predisposition to Disease Genetic Testing Gynecology. Andrology. Obstetrics Humans Mammary gland diseases Medical History Taking Medical sciences Ovarian Neoplasms - genetics Pedigree Pharmacology. Drug treatments Practice Guidelines as Topic Risk Factors Tumors Europe Mammary gland diseases Ovarian diseases Ovary cancer Genetics Breast cancer Malignant tumor Hereditary Recommendation Female genital diseases
Online Access	Get full text
ISSN	0923-7534 1569-8041
DOI	10.1093/annonc/mdh917

Cover

Author	Eccles, D.M.
Author_xml	– sequence: 1 givenname: D.M. surname: Eccles fullname: Eccles, D.M. organization: Princess Anne Hospital, Wessex Clinical Genetics Service, Southampton, UK
BackLink	http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16313797$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15477297$$D View this record in MEDLINE/PubMed
BookMark	eNp10UFvFCEUB3Biauy2evRquOhtWhhgAG-6sa7JJl6qMV7IW3hT0VlmhdlGv73ojDYx6QlCfo-X9_5n5CSNCQl5ytkFZ1ZcQqoP_nIfvliuH5AVV51tDJP8hKyYbUWjlZCn5KyUr4yxzrb2ETnlSmrdWr0iHzeYMcQJ8k_qIXnML-nNMQYcYsJCY6K-3qKHgR4y-Cl6vKCvM0KZKKRAx1vIEdJSS28wYTXlMXnYw1DwyXKekw9Xb67Xm2b7_u279att46WUUwPecA18xzsfsO9aztlOGhOMDiCEbBVjxirA1qMxKuy8UVK0urfAgLdWiXPyYv73kMfvRyyT28ficRgg4XgsruusMtzqCp8t8LjbY3CHHPd1Zvd3ExU8XwCUOm2f60Cx3LlOcKH_uGZ2Po-lZOzvCHO_E3FzIm5OpHrxn_d121Mc05QhDvdWLV1imfDHvxaQv7lOC63c5tNnt71aG33dCmeq17PHuuzbiNkVH7FGEmJGP7kwxns6_QKNELRl
CitedBy_id	crossref_primary_10_1152_japplphysiol_00319_2011 crossref_primary_10_21294_1814_4861_2022_21_6_145_155 crossref_primary_10_1007_s10549_015_3604_z crossref_primary_10_1016_j_critrevonc_2008_06_003 crossref_primary_10_1016_S0140_6736_05_67601_5 crossref_primary_10_1080_13697130601022367 crossref_primary_10_3233_CBM_161649 crossref_primary_10_1080_20786204_2007_10873634 crossref_primary_10_1186_1897_4287_8_8 crossref_primary_10_1002_cncr_22082 crossref_primary_10_1007_s12687_016_0271_7 crossref_primary_10_21294_1814_4861_2022_21_4_72_79 crossref_primary_10_1007_s10549_009_0486_y crossref_primary_10_1016_j_soncn_2006_11_002 crossref_primary_10_21294_1814_4861_2021_20_6_164_170 crossref_primary_10_1080_20742835_2009_11441131
Cites_doi	10.1034/j.1399-0004.2003.00097.x 10.1016/S0140-6736(02)09962-2 10.1038/ng879 10.1016/S0277-9536(03)00263-6 10.1200/JCO.2003.02.107 10.1200/JCO.1999.17.11.3396 10.1054/bjoc.2001.1777 10.1016/S0140-6736(95)92655-0 10.1023/A:1013867917101 10.1038/378789a0 10.1200/JCO.2001.19.15.3524 10.1038/bjc.1998.366 10.1056/NEJM199704173361602 10.1023/A:1021135807900 10.1136/bmj.322.7293.1040 10.1054/bjoc.2000.1239 10.1016/S0140-6736(05)64963-X 10.1186/bcr658 10.1093/jnci/94.3.205 10.1126/science.2270482 10.1126/science.7545954 10.1016/S0140-6736(02)07746-2 10.1016/S0140-6736(01)06039-1 10.1056/NEJM200102223440801 10.1200/JCO.2002.05.121 10.1093/jnci/91.24.2112 10.1016/S0140-6736(03)12856-5 10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V 10.1073/pnas.0533805100 10.1200/JCO.2002.09.023 10.1097/00000478-200110000-00009 10.1016/S0140-6736(02)08434-9 10.1002/gepi.1014 10.1634/theoncologist.9-1-13 10.1200/JCO.1999.17.10.3017 10.1200/JCO.2000.18.24.4053 10.1038/82533 10.1093/jnci/djg050 10.1016/S0140-6736(97)07065-7
ContentType	Journal Article Conference Proceeding
Copyright	2004 European Society for Medical Oncology 2005 INIST-CNRS
Copyright_xml	– notice: 2004 European Society for Medical Oncology – notice: 2005 INIST-CNRS
DBID	6I. AAFTH BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1093/annonc/mdh917
DatabaseName	ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1569-8041
EndPage	iv138
ExternalDocumentID	15477297 16313797 10_1093_annonc_mdh917 ark_67375_HXZ_LFC87T23_8 S0923753419531623
Genre	Journal Article Review
GeographicLocations	Europe
GeographicLocations_xml	– name: Europe
GrantInformation_xml	– fundername: European Society for Medical Oncology (ESMO)
GroupedDBID	--- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6I. 6J9 70D AABJS AABMN AAEDW AAESY AAFTH AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 AAGQS AALRI AAYWO ABNGD ACUKT ACVFH ADCNI ADVLN AEHUL AEUPX AFJKZ AFPUW AFSHK AGCQF AGQPQ AIGII AKBMS AKRWK AKYEP APXCP BSCLL EFKBS H13 AAYXX AFETI CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-c444t-ac817a1b16cdef62110b488d87da3342500895ae2ce885dbc854327f9a0a12953
ISSN	0923-7534
IngestDate	Thu Sep 04 20:42:40 EDT 2025 Wed Jul 23 00:57:57 EDT 2025 Mon Jul 21 09:17:34 EDT 2025 Tue Jul 01 02:09:51 EDT 2025 Thu Apr 24 23:06:37 EDT 2025 Sat Sep 20 11:02:11 EDT 2025 Fri Feb 23 02:47:01 EST 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	suppl-4
Keywords	Mammary gland diseases Ovarian diseases Ovary cancer Genetics Breast cancer Malignant tumor Hereditary Recommendation Female genital diseases
Language	English
License	http://www.elsevier.com/open-access/userlicense/1.0 https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0
LinkModel	OpenURL
MeetingName	Educational Book of the 29th ESMO Congress, 29 October-2 November, 2004: Vienna, Austria
MergedId	FETCHMERGED-LOGICAL-c444t-ac817a1b16cdef62110b488d87da3342500895ae2ce885dbc854327f9a0a12953
Notes	href:mdh917.pdf local:mdh917 istex:39396BF682FBFB5AC4DB9A8403635100E7CD728B ark:/67375/HXZ-LFC87T23-8 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
OpenAccessLink	https://dx.doi.org/10.1093/annonc/mdh917
PMID	15477297
PQID	66958197
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_66958197 pubmed_primary_15477297 pascalfrancis_primary_16313797 crossref_primary_10_1093_annonc_mdh917 crossref_citationtrail_10_1093_annonc_mdh917 istex_primary_ark_67375_HXZ_LFC87T23_8 elsevier_sciencedirect_doi_10_1093_annonc_mdh917
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2004-01-01
PublicationDateYYYYMMDD	2004-01-01
PublicationDate_xml	– month: 01 year: 2004 text: 2004-01-01 day: 01
PublicationDecade	2000
PublicationPlace	Oxford
PublicationPlace_xml	– name: Oxford – name: England
PublicationTitle	Annals of oncology
PublicationTitleAlternate	Ann Oncol
PublicationYear	2004
Publisher	Elsevier Ltd Oxford University Press
Publisher_xml	– name: Elsevier Ltd – name: Oxford University Press
References	Wooster, Bignell, Lancaster (bb0030) 1995; 378 Verhoog, Brekelmans, Seynaeve (bb0160) 1999; 17 Thull, Vogel (bb0125) 2004; 9 Haffty, Harrold, Khan (bb0190) 2002; 359 Chenevix-Trench, Spurdle, Gatei (bb0035) 2002; 94 (bb0085) 2002; 360 Scott, Iorgulescu, Thorne (bb0105) 2003; 64 Eccles, Englefield, Soulby, Campbell (bb0135) 1998; 77 Robson, Levin, Federici (bb0180) 1999; 91 Kadouri, Easton, Edwards (bb0120) 2001; 85 Petricoin, Ardekani, Hitt (bb0080) 2002; 359 Bouchard, Blancquaert, Eisinger (bb0100) 2004; 58 Lakhani, Van De Vijver, Jacquemier (bb0145) 2002; 20 Turner, Harrold, Matloff (bb0185) 1999; 17 Miki, Swensen, Shattuck-Eidens (bb0025) 1994; 266 Narod, Brunet, Ghadirian (bb0090) 2000; 356 Wright, Mueller (bb0060) 1995; 346 Warner, Plewes, Shumak (bb0075) 2001; 19 Colgan, Murphy, Cole (bb0110) 2001; 25 Eccles, Simmonds, Goddard (bb0155) 2001; 1 Antoniou, Pharoah, McMullan (bb0010) 2001; 21 Stoppa-Lyonnet, Ansquer, Dreyfus (bb0170) 2000; 18 Hall, Lee, Newman (bb0020) 1990; 250 Quinn, Kennedy, Mullan (bb0205) 2003; 63 Hedenfalk, Duggan, Chen (bb0220) 2001; 344 Evans, Lalloo, Shenton (bb0095) 2001; 358 Verhoog, Brekelmans, Seynaeve (bb0165) 1998; 351 Robson, Chappuis, Satagopan (bb0210) 2004; 6 Foulkes, Stefansson, Chappuis (bb0150) 2003; 95 Lalloo, Varley, Ellis (bb0130) 2003; 361 Verhoog, Brekelmans, Seynaeve (bb0175) 2000; 83 Suter, Malone, Daling (bb0115) 2003; 12 Tabar, Vitak, Chen (bb0065) 2001; 91 Narod, Brunet, Ghadirian (bb0195) 2000; 356 Lucassen, Watson, Eccles (bb0070) 2001; 322 Hedenfalk, Ringner, Ben Dor (bb0215) 2003; 100 Stratton, Gayther, Russell (bb0140) 1997; 336 Peshkin, Isaacs, Finch (bb0200) 2003; 21 Peto, Mack (bb0005) 2000; 26 Claus, Risch, Thompson (bb0015) 1994; 73 Berry, Iversen, Gudbjartsson (bb0055) 2002; 20 Evans, Kerr, Cade (bb0045) 1996; 348 Meijers-Heijboer, Van Den, Klijn (bb0040) 2002; 31 Claus (bb0050) 2001; 1 (10.1093/annonc/mdh917_bb0085) 2002; 360 Wooster (10.1093/annonc/mdh917_bb0030) 1995; 378 Antoniou (10.1093/annonc/mdh917_bb0010) 2001; 21 Berry (10.1093/annonc/mdh917_bb0055) 2002; 20 Meijers-Heijboer (10.1093/annonc/mdh917_bb0040) 2002; 31 Robson (10.1093/annonc/mdh917_bb0180) 1999; 91 Quinn (10.1093/annonc/mdh917_bb0205) 2003; 63 Stratton (10.1093/annonc/mdh917_bb0140) 1997; 336 Peshkin (10.1093/annonc/mdh917_bb0200) 2003; 21 Peto (10.1093/annonc/mdh917_bb0005) 2000; 26 Hedenfalk (10.1093/annonc/mdh917_bb0215) 2003; 100 Petricoin (10.1093/annonc/mdh917_bb0080) 2002; 359 Kadouri (10.1093/annonc/mdh917_bb0120) 2001; 85 Lucassen (10.1093/annonc/mdh917_bb0070) 2001; 322 Verhoog (10.1093/annonc/mdh917_bb0175) 2000; 83 Verhoog (10.1093/annonc/mdh917_bb0165) 1998; 351 Narod (10.1093/annonc/mdh917_bb0195) 2000; 356 Lakhani (10.1093/annonc/mdh917_bb0145) 2002; 20 Evans (10.1093/annonc/mdh917_bb0095) 2001; 358 Hedenfalk (10.1093/annonc/mdh917_bb0220) 2001; 344 Colgan (10.1093/annonc/mdh917_bb0110) 2001; 25 Chenevix-Trench (10.1093/annonc/mdh917_bb0035) 2002; 94 Lalloo (10.1093/annonc/mdh917_bb0130) 2003; 361 Claus (10.1093/annonc/mdh917_bb0050) 2001; 1 Suter (10.1093/annonc/mdh917_bb0115) 2003; 12 Verhoog (10.1093/annonc/mdh917_bb0160) 1999; 17 Thull (10.1093/annonc/mdh917_bb0125) 2004; 9 Robson (10.1093/annonc/mdh917_bb0210) 2004; 6 Haffty (10.1093/annonc/mdh917_bb0190) 2002; 359 Wright (10.1093/annonc/mdh917_bb0060) 1995; 346 Evans (10.1093/annonc/mdh917_bb0045) 1996; 348 Bouchard (10.1093/annonc/mdh917_bb0100) 2004; 58 Scott (10.1093/annonc/mdh917_bb0105) 2003; 64 Claus (10.1093/annonc/mdh917_bb0015) 1994; 73 Miki (10.1093/annonc/mdh917_bb0025) 1994; 266 Hall (10.1093/annonc/mdh917_bb0020) 1990; 250 Eccles (10.1093/annonc/mdh917_bb0135) 1998; 77 Foulkes (10.1093/annonc/mdh917_bb0150) 2003; 95 Eccles (10.1093/annonc/mdh917_bb0155) 2001; 1 Stoppa-Lyonnet (10.1093/annonc/mdh917_bb0170) 2000; 18 Tabar (10.1093/annonc/mdh917_bb0065) 2001; 91 Narod (10.1093/annonc/mdh917_bb0090) 2000; 356 Turner (10.1093/annonc/mdh917_bb0185) 1999; 17 Warner (10.1093/annonc/mdh917_bb0075) 2001; 19
References_xml	– volume: 94 start-page: 205 year: 2002 end-page: 215 ident: bb0035 article-title: Dominant negative ATM mutations in breast cancer families publication-title: J Natl Cancer Inst – volume: 20 start-page: 2701 year: 2002 end-page: 2712 ident: bb0055 article-title: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes publication-title: J Clin Oncol – volume: 63 start-page: 6221 year: 2003 end-page: 6228 ident: bb0205 article-title: BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis publication-title: Cancer Res – volume: 336 start-page: 1125 year: 1997 end-page: 1130 ident: bb0140 article-title: Contribution of BRCA1 mutations to ovarian cancer publication-title: N Engl J Med – volume: 95 start-page: 1482 year: 2003 end-page: 1485 ident: bb0150 article-title: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer publication-title: J Natl Cancer Inst – volume: 25 start-page: 1283 year: 2001 end-page: 1289 ident: bb0110 article-title: Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status publication-title: Am J Surg Pathol – volume: 266 start-page: 66 year: 1994 end-page: 71 ident: bb0025 article-title: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 publication-title: Science – volume: 91 start-page: 1724 year: 2001 end-page: 1731 ident: bb0065 article-title: Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality publication-title: Cancer – volume: 17 start-page: 3017 year: 1999 end-page: 3024 ident: bb0185 article-title: BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations publication-title: J Clin Oncol – volume: 344 start-page: 539 year: 2001 end-page: 548 ident: bb0220 article-title: Gene-expression profiles in hereditary breast cancer publication-title: N Engl J Med – volume: 358 start-page: 889 year: 2001 end-page: 890 ident: bb0095 article-title: Uptake of screening and prevention in women at very high risk of breast cancer publication-title: Lancet – volume: 17 start-page: 3396 year: 1999 end-page: 3402 ident: bb0160 article-title: Survival in hereditary breast cancer associated with germline mutations of BRCA2 publication-title: J Clin Oncol – volume: 21 start-page: 4322 year: 2003 end-page: 4328 ident: bb0200 article-title: Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians publication-title: J Clin Oncol – volume: 18 start-page: 4053 year: 2000 end-page: 4059 ident: bb0170 article-title: Familial invasive breast cancers: worse outcome related to BRCA1 mutations publication-title: J Clin Oncol – volume: 346 start-page: 29 year: 1995 end-page: 32 ident: bb0060 article-title: Screening mammography and public health policy: the need for perspective publication-title: Lancet – volume: 100 start-page: 2532 year: 2003 end-page: 2537 ident: bb0215 article-title: Molecular classification of familial non-BRCA1/BRCA2 breast cancer publication-title: Proc Natl Acad Sci USA – volume: 64 start-page: 111 year: 2003 end-page: 121 ident: bb0105 article-title: Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy publication-title: Clin Genet – volume: 91 start-page: 2112 year: 1999 end-page: 2117 ident: bb0180 article-title: Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations publication-title: J Natl Cancer Inst – volume: 12 start-page: 127 year: 2003 end-page: 135 ident: bb0115 article-title: Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women publication-title: Cancer Epidemiol Biomarkers Prev – volume: 360 start-page: 817 year: 2002 end-page: 824 ident: bb0085 article-title: First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial publication-title: Lancet – volume: 6 start-page: R8 year: 2004 end-page: R17 ident: bb0210 article-title: A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment publication-title: Breast Cancer Res – volume: 26 start-page: 411 year: 2000 end-page: 414 ident: bb0005 article-title: High constant incidence in twins and other relatives of women with breast cancer publication-title: Nat Genet – volume: 356 start-page: 1876 year: 2000 end-page: 1881 ident: bb0090 article-title: Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study publication-title: Hereditary Breast Cancer Clinical Study Group. Lancet – volume: 361 start-page: 1101 year: 2003 end-page: 1102 ident: bb0130 article-title: Prediction of pathogenic mutations in patients with early-onset breast cancer by family history publication-title: Lancet – volume: 73 start-page: 643 year: 1994 end-page: 651 ident: bb0015 article-title: Autosomal dominant inheritance of early-onset breast cancer publication-title: Implications for risk prediction. Cancer – volume: 348 start-page: 1034 year: 1996 ident: bb0045 article-title: Fictitious breast cancer family history publication-title: Lancet – volume: 250 start-page: 1684 year: 1990 end-page: 1689 ident: bb0020 article-title: Linkage of early-onset familial breast cancer to chromosome 17q21 publication-title: Science – volume: 77 start-page: 2199 year: 1998 end-page: 2203 ident: bb0135 article-title: BRCA1 mutations in southern England publication-title: Br J Cancer – volume: 1 start-page: 65 year: 2001 end-page: 72 ident: bb0155 article-title: Familial Breast Cancer: an investigation into the outcome of treatment for early stage disease publication-title: Fam Cancer – volume: 1 start-page: 197 year: 2001 end-page: 206 ident: bb0050 article-title: Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians publication-title: Fam Cancer – volume: 58 start-page: 1085 year: 2004 end-page: 1096 ident: bb0100 article-title: Prevention and genetic testing for breast cancer: variations in medical decisions publication-title: Soc Sci Med – volume: 85 start-page: 36 year: 2001 end-page: 40 ident: bb0120 article-title: CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers publication-title: Br J Cancer – volume: 378 start-page: 789 year: 1995 end-page: 792 ident: bb0030 article-title: Identification of the breast cancer susceptibility gene BRCA2 publication-title: Nature – volume: 20 start-page: 2310 year: 2002 end-page: 2318 ident: bb0145 article-title: The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 publication-title: J Clin Oncol – volume: 359 start-page: 1471 year: 2002 end-page: 1477 ident: bb0190 article-title: Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status publication-title: Lancet – volume: 356 start-page: 1876 year: 2000 end-page: 1881 ident: bb0195 article-title: Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study publication-title: Hereditary Breast Cancer Clinical Study Group. Lancet – volume: 83 start-page: 384 year: 2000 end-page: 386 ident: bb0175 article-title: Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer publication-title: Br J Cancer – volume: 351 start-page: 316 year: 1998 end-page: 321 ident: bb0165 article-title: Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 publication-title: Lancet – volume: 19 start-page: 3524 year: 2001 end-page: 3531 ident: bb0075 article-title: Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer publication-title: J Clin Oncol – volume: 9 start-page: 13 year: 2004 end-page: 24 ident: bb0125 article-title: Recognition and management of hereditary breast cancer syndromes publication-title: Oncologist – volume: 21 start-page: 1 year: 2001 end-page: 18 ident: bb0010 article-title: Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study publication-title: Genet Epidemiol – volume: 322 start-page: 1040 year: 2001 end-page: 1042 ident: bb0070 article-title: Evidence based case report: Advice about mammography for a young woman with a family history of breast cancer publication-title: BMJ – volume: 359 start-page: 572 year: 2002 end-page: 577 ident: bb0080 article-title: Use of proteomic patterns in serum to identify ovarian cancer publication-title: Lancet – volume: 31 start-page: 55 year: 2002 end-page: 59 ident: bb0040 article-title: Low-penetrance susceptibility to breast cancer due to CHEK2()1100delC in noncarriers of BRCA1 or BRCA2 mutations publication-title: Nat Genet – volume: 64 start-page: 111 year: 2003 ident: 10.1093/annonc/mdh917_bb0105 article-title: Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy publication-title: Clin Genet doi: 10.1034/j.1399-0004.2003.00097.x – volume: 360 start-page: 817 year: 2002 ident: 10.1093/annonc/mdh917_bb0085 article-title: First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial publication-title: Lancet doi: 10.1016/S0140-6736(02)09962-2 – volume: 31 start-page: 55 year: 2002 ident: 10.1093/annonc/mdh917_bb0040 article-title: Low-penetrance susceptibility to breast cancer due to CHEK2()1100delC in noncarriers of BRCA1 or BRCA2 mutations publication-title: Nat Genet doi: 10.1038/ng879 – volume: 58 start-page: 1085 year: 2004 ident: 10.1093/annonc/mdh917_bb0100 article-title: Prevention and genetic testing for breast cancer: variations in medical decisions publication-title: Soc Sci Med doi: 10.1016/S0277-9536(03)00263-6 – volume: 21 start-page: 4322 year: 2003 ident: 10.1093/annonc/mdh917_bb0200 article-title: Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians publication-title: J Clin Oncol doi: 10.1200/JCO.2003.02.107 – volume: 17 start-page: 3396 year: 1999 ident: 10.1093/annonc/mdh917_bb0160 article-title: Survival in hereditary breast cancer associated with germline mutations of BRCA2 publication-title: J Clin Oncol doi: 10.1200/JCO.1999.17.11.3396 – volume: 85 start-page: 36 year: 2001 ident: 10.1093/annonc/mdh917_bb0120 article-title: CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers publication-title: Br J Cancer doi: 10.1054/bjoc.2001.1777 – volume: 356 start-page: 1876 year: 2000 ident: 10.1093/annonc/mdh917_bb0195 article-title: Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study publication-title: Hereditary Breast Cancer Clinical Study Group. Lancet – volume: 346 start-page: 29 year: 1995 ident: 10.1093/annonc/mdh917_bb0060 article-title: Screening mammography and public health policy: the need for perspective publication-title: Lancet doi: 10.1016/S0140-6736(95)92655-0 – volume: 63 start-page: 6221 year: 2003 ident: 10.1093/annonc/mdh917_bb0205 article-title: BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis publication-title: Cancer Res – volume: 356 start-page: 1876 year: 2000 ident: 10.1093/annonc/mdh917_bb0090 article-title: Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study publication-title: Hereditary Breast Cancer Clinical Study Group. Lancet – volume: 1 start-page: 65 year: 2001 ident: 10.1093/annonc/mdh917_bb0155 article-title: Familial Breast Cancer: an investigation into the outcome of treatment for early stage disease publication-title: Fam Cancer doi: 10.1023/A:1013867917101 – volume: 378 start-page: 789 year: 1995 ident: 10.1093/annonc/mdh917_bb0030 article-title: Identification of the breast cancer susceptibility gene BRCA2 publication-title: Nature doi: 10.1038/378789a0 – volume: 19 start-page: 3524 year: 2001 ident: 10.1093/annonc/mdh917_bb0075 article-title: Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2001.19.15.3524 – volume: 77 start-page: 2199 year: 1998 ident: 10.1093/annonc/mdh917_bb0135 article-title: BRCA1 mutations in southern England publication-title: Br J Cancer doi: 10.1038/bjc.1998.366 – volume: 336 start-page: 1125 year: 1997 ident: 10.1093/annonc/mdh917_bb0140 article-title: Contribution of BRCA1 mutations to ovarian cancer publication-title: N Engl J Med doi: 10.1056/NEJM199704173361602 – volume: 1 start-page: 197 year: 2001 ident: 10.1093/annonc/mdh917_bb0050 article-title: Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians publication-title: Fam Cancer doi: 10.1023/A:1021135807900 – volume: 322 start-page: 1040 year: 2001 ident: 10.1093/annonc/mdh917_bb0070 article-title: Evidence based case report: Advice about mammography for a young woman with a family history of breast cancer publication-title: BMJ doi: 10.1136/bmj.322.7293.1040 – volume: 83 start-page: 384 year: 2000 ident: 10.1093/annonc/mdh917_bb0175 article-title: Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer publication-title: Br J Cancer doi: 10.1054/bjoc.2000.1239 – volume: 348 start-page: 1034 year: 1996 ident: 10.1093/annonc/mdh917_bb0045 article-title: Fictitious breast cancer family history publication-title: Lancet doi: 10.1016/S0140-6736(05)64963-X – volume: 6 start-page: R8 year: 2004 ident: 10.1093/annonc/mdh917_bb0210 article-title: A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment publication-title: Breast Cancer Res doi: 10.1186/bcr658 – volume: 94 start-page: 205 year: 2002 ident: 10.1093/annonc/mdh917_bb0035 article-title: Dominant negative ATM mutations in breast cancer families publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.3.205 – volume: 12 start-page: 127 year: 2003 ident: 10.1093/annonc/mdh917_bb0115 article-title: Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women publication-title: Cancer Epidemiol Biomarkers Prev – volume: 73 start-page: 643 year: 1994 ident: 10.1093/annonc/mdh917_bb0015 article-title: Autosomal dominant inheritance of early-onset breast cancer publication-title: Implications for risk prediction. Cancer – volume: 250 start-page: 1684 year: 1990 ident: 10.1093/annonc/mdh917_bb0020 article-title: Linkage of early-onset familial breast cancer to chromosome 17q21 publication-title: Science doi: 10.1126/science.2270482 – volume: 266 start-page: 66 year: 1994 ident: 10.1093/annonc/mdh917_bb0025 article-title: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 publication-title: Science doi: 10.1126/science.7545954 – volume: 359 start-page: 572 year: 2002 ident: 10.1093/annonc/mdh917_bb0080 article-title: Use of proteomic patterns in serum to identify ovarian cancer publication-title: Lancet doi: 10.1016/S0140-6736(02)07746-2 – volume: 358 start-page: 889 year: 2001 ident: 10.1093/annonc/mdh917_bb0095 article-title: Uptake of screening and prevention in women at very high risk of breast cancer publication-title: Lancet doi: 10.1016/S0140-6736(01)06039-1 – volume: 344 start-page: 539 year: 2001 ident: 10.1093/annonc/mdh917_bb0220 article-title: Gene-expression profiles in hereditary breast cancer publication-title: N Engl J Med doi: 10.1056/NEJM200102223440801 – volume: 20 start-page: 2701 year: 2002 ident: 10.1093/annonc/mdh917_bb0055 article-title: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes publication-title: J Clin Oncol doi: 10.1200/JCO.2002.05.121 – volume: 91 start-page: 2112 year: 1999 ident: 10.1093/annonc/mdh917_bb0180 article-title: Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations publication-title: J Natl Cancer Inst doi: 10.1093/jnci/91.24.2112 – volume: 361 start-page: 1101 year: 2003 ident: 10.1093/annonc/mdh917_bb0130 article-title: Prediction of pathogenic mutations in patients with early-onset breast cancer by family history publication-title: Lancet doi: 10.1016/S0140-6736(03)12856-5 – volume: 91 start-page: 1724 year: 2001 ident: 10.1093/annonc/mdh917_bb0065 article-title: Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality publication-title: Cancer doi: 10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V – volume: 100 start-page: 2532 year: 2003 ident: 10.1093/annonc/mdh917_bb0215 article-title: Molecular classification of familial non-BRCA1/BRCA2 breast cancer publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0533805100 – volume: 20 start-page: 2310 year: 2002 ident: 10.1093/annonc/mdh917_bb0145 article-title: The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 publication-title: J Clin Oncol doi: 10.1200/JCO.2002.09.023 – volume: 25 start-page: 1283 year: 2001 ident: 10.1093/annonc/mdh917_bb0110 article-title: Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status publication-title: Am J Surg Pathol doi: 10.1097/00000478-200110000-00009 – volume: 359 start-page: 1471 year: 2002 ident: 10.1093/annonc/mdh917_bb0190 article-title: Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status publication-title: Lancet doi: 10.1016/S0140-6736(02)08434-9 – volume: 21 start-page: 1 year: 2001 ident: 10.1093/annonc/mdh917_bb0010 article-title: Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study publication-title: Genet Epidemiol doi: 10.1002/gepi.1014 – volume: 9 start-page: 13 year: 2004 ident: 10.1093/annonc/mdh917_bb0125 article-title: Recognition and management of hereditary breast cancer syndromes publication-title: Oncologist doi: 10.1634/theoncologist.9-1-13 – volume: 17 start-page: 3017 year: 1999 ident: 10.1093/annonc/mdh917_bb0185 article-title: BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations publication-title: J Clin Oncol doi: 10.1200/JCO.1999.17.10.3017 – volume: 18 start-page: 4053 year: 2000 ident: 10.1093/annonc/mdh917_bb0170 article-title: Familial invasive breast cancers: worse outcome related to BRCA1 mutations publication-title: J Clin Oncol doi: 10.1200/JCO.2000.18.24.4053 – volume: 26 start-page: 411 year: 2000 ident: 10.1093/annonc/mdh917_bb0005 article-title: High constant incidence in twins and other relatives of women with breast cancer publication-title: Nat Genet doi: 10.1038/82533 – volume: 95 start-page: 1482 year: 2003 ident: 10.1093/annonc/mdh917_bb0150 article-title: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djg050 – volume: 351 start-page: 316 year: 1998 ident: 10.1093/annonc/mdh917_bb0165 article-title: Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 publication-title: Lancet doi: 10.1016/S0140-6736(97)07065-7
SSID	ssj0006929
Score	1.8301133
SecondaryResourceType	review_article
SourceID	proquest pubmed pascalfrancis crossref istex elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	iv133
SubjectTerms	Antineoplastic agents Biological and medical sciences Breast Neoplasms - genetics Europe Female Female genital diseases Genes, BRCA1 Genes, BRCA2 Genetic Predisposition to Disease Genetic Testing Gynecology. Andrology. Obstetrics Humans Mammary gland diseases Medical History Taking Medical sciences Ovarian Neoplasms - genetics Pedigree Pharmacology. Drug treatments Practice Guidelines as Topic Risk Factors Tumors
Title	Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics
URI	https://dx.doi.org/10.1093/annonc/mdh917 https://api.istex.fr/ark:/67375/HXZ-LFC87T23-8/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/15477297 https://www.proquest.com/docview/66958197
Volume	15
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1569-8041 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0006929 issn: 0923-7534 databaseCode: DIK dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1569-8041 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0006929 issn: 0923-7534 databaseCode: GX1 dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLZgkxC3AQM6YPiAOJGuSezY4Vo2FRiIQ4cqLpbtOGMCUtS1E_DX817sJO1ohECqojRy7Mif8_y9l_eDkGdCy1EBmlUEeIuIlSKOTGLKyDFdWgM_q2tvi_fZ5Iy9mfFZU2g8RJcszdD-2hpX8j-owjXAFaNk_wHZtlO4AOeALxwBYTj-ifHWrabLfzyv7JqFPBT-wUKcoPwvfqJzl3V1ScjzFWa2Qm93tHW0kZFNuNQQ4MZ6PvVXhfkVqNIgAfzdWG4ZYx47Gj4enx7Xvn-vhsGs2hgQ2DUDQk9g4rqlMEkj0GrYhtDka1Lv4ir22SzCFor_5Vb57HNX6aqCSYGTb8Xn3IdubmbCvrZDtX6DQB7jVOTiJtlNUlDqkQS_ftvuvFme-NyK4YFDTlUY9MgPeeQH7OMgu_hm_UD3WH0JM1_60ib9ukfNQaZ7ZL-LzqQf2sVwh9xw1V1y611wkrhHPnawUw_cS9qBTi8q2oBOW9CpB50C6DSAHu6lDej75OzkeDqeRKF8RmQZY8tIWxkLHZs4s4UrM9T0DYjrQopCpynIaqB_OdcusU5KXhgrOUsTUeZ6pIEF8vQ-2YFJcw8JFTkvEuDaxsUYuK2lzEdGaA2dGGDsZkBeNBOqbMgtjyVOvirv45AqP__Kz_-APG-bf_dJVfoajhp0VGCEnukpWFC9fdcoth3rxRd0XhRcTWaf1OnJWIppkio5IIcbMHdPEhbZgDxtcFcgc_FDmq7cfHWpsiznwKShxQO_HLp7OUN1VRz8rfNH5Hb3Lj4mO8vFyj0Bers0h_Wa_g2Snarf
linkProvider	Flying Publisher
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Annals+of+oncology&rft.atitle=Hereditary+cancer%3A+guidelines+in+clinical+practice.+Breast+and+ovarian+cancer+genetics&rft.au=ECCLES%2C+D.+M&rft.date=2004-01-01&rft.pub=Oxford+University+Press&rft.issn=0923-7534&rft.volume=15&rft.spage=iv133&rft.epage=iv138&rft_id=info:doi/10.1093%2Fannonc%2Fmdh917&rft.externalDBID=n%2Fa&rft.externalDocID=16313797
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon